(Q48290602)

10 February 2018

title

Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging (English)

1 reference

10 February 2018

7

Guy Bormans

1 reference

10 February 2018

author name string

Koen Van Laere

1

1 reference

10 February 2018

Rawaha U Ahmad

2

1 reference

10 February 2018

Hendra Hudyana

3

1 reference

10 February 2018

Sofie Celen

4

1 reference

10 February 2018

Kristof Dubois

5

1 reference

10 February 2018

Mark E Schmidt

6

1 reference

10 February 2018

Michel Koole

8

1 reference

10 February 2018

publication date

16 November 2012

1 reference

10 February 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

10 February 2018

volume

40

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

254-261

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00259-012-2270-1

exact match

0 references

cites work

Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Immunohistochemical localization of PDE10A in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

[CT-expo--a novel program for dose evaluation in CT]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2270-1

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23160998

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dose to the Fetus from Radionuclides in the Bladder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23160998

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-012-2270-1

1 reference

10 February 2018

release_ea46rk4vd5bu5k6odynekaa7uu

Fatcat ID

0 references

1 reference

10 February 2018